We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
133 hedge funds and large institutions have $268M invested in Esperion Therapeutics in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 45 increasing their positions, 26 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
96.54% more ownership
Funds ownership: 87.84% → 184.38% (+97%)
73% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 26
46% more call options, than puts
Call options by funds: $5.13M | Put options by funds: $3.51M
4% less funds holding
Funds holding: 139 → 133 (-6)
10% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 49
10% less capital invested
Capital invested by funds: $299M → $268M (-$31.1M)
Holders
133
Holders Change
-6
Holders Change %
-4.32%
% of All Funds
2.05%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
44
Increased
45
Reduced
26
Closed
49
Calls
$5.13M
Puts
$3.51M
Net Calls
+$1.61M
Net Calls Change
+$3.75M
Top Buyers
| 1 |
DM
Deerfield Management
New York
|
+$40M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$24.9M |
| 3 |
ACM
Altium Capital Management
New York
|
+$20.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.4M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$13.2M |
Top Sellers
| 1 |
Marshall Wace
London,
United Kingdom
|
-$6.27M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.54M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.99M |
| 4 |
LA
Linden Advisors
New York
|
-$1.41M |
| 5 |
CCM
Cinctive Capital Management
New York
|
-$1.33M |
